New hope to protect Kids' bones after Life-Saving transplants
NCT ID NCT07375290
Summary
This study is testing if giving a bone-strengthening medication called zoledronate early can safely prevent bone disease and fractures in children who have had a stem cell transplant. It focuses on children aged 5 to 18 who are at high risk for bone problems. The goal is to see if this early approach can reduce future pain and suffering by stopping bone issues before they start.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOPOIETIC STEM CELL TRANSPLANTATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cincinnati Children's Hospital Medical Center
RECRUITINGCincinnati, Ohio, 45229, United States
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.